Haematologica
Collection
Collection
- ISSN: 03906078
-
Influence of genetic polymorphisms in CYP3A4, CYP3AS, GSTP1, GSTM1, GSTT1 and MDR1 genes on survival and therapy-related toxicity in multiple myeloma Article
Haematologica, 92(2), 277-278.C. Schilthuizen (Céline), A. Broyl (Annemiek), B. van der Holt (Bronno), Y. de Knegt (Yvonne), H.M. Lokhorst (Henk) and P. Sonneveld (Pieter)
February 2007 -
Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma Article
Haematologica, 92(2), 279-280.M. Verduijn (Marion), M. Verduijn (Marion), M. Verduijn (Marion) and M. Verduijn (Marion)
February 2007 -
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia Article
Haematologica, 92(3), 397-400.A. Yoshimi (Ayami), I. Baumann (Irith), M. Führer (Monika), E. Bergsträsser (Eva), U. Göbel (Ulrich), K.-W. Sykora, T. Klingebiel (Thomas), U. Gross-Wieltsch (Ute), M.M. van den Heuvel-Eibrink (Marry), A. Fischer (Alexandra), et al. P. Nöllke (Peter) and C.M. Niemeyer (Charlotte)
March 2007 -
Clinically and genetically atypical T-cell prolymphocytic leukemia underlines the relevance of a multidisciplinary diagnostic approach. Article
Haematologica, 92(3)Y. Sandberg (Yorick), K.L. Wu (Ka), F. Heule (Freerk), R.R. van den Bos (Renate), K.H. Lam (King), A.W. Langerak (Anton), V.H.J. van der Velden (Vincent), K. van Lom (Kirsten) and H.B. Beverloo (Berna)
March 2007 -
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: Long-term follow-up of the Dutch Cooperative Group HOVON 24 trial Article
Haematologica, 92(7), 928-935.P. Sonneveld (Pieter), B. van der Holt (Bronno), C.M. Segeren (Christine), E. Vellenga (Edo), A.J. Croockewit (Alexandra), G.E.G. Verhoef (Gregor), J.J. Cornelissen (Jan), M.R. Schaafsma (Martijn), M.H.J. van Oers (Marinus), P.W. Wijermans (Pierre), et al. P.H.M. Westveer (Petra) and H.M. Lokhorst (Henk)
July 2007 -
IL-7 mediated protection against minor antigen-mismatched allograft rejection is associated with enhanced recovery of regulatory T cells Article
Haematologica, 92(8), 1099-1106.A.E.C. Broers (Annoek), M. Bruinsma (Marieke), S.J. Posthumus-van Sluijs (Sandra), E-J. Wils (Evert-Jan), H. Spits (Hergen), B. Löwenberg (Bob), E. Braakman (Eric) and J.J. Cornelissen (Jan)
August 2007 -
Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients Article
Haematologica, 92(8), 1123-1126.F.P.G. Silva (Fernando), A. Lind (Alexandra), G. Brouwer-Mandema (Geeske), P.J.M. Valk (Peter) and M. Giphart-Gassler (Micheline)
August 2007 -
Role of mutation independent constitutive activation of FLT3 in juvenile myelomonocytic leukemia Article
Haematologica, 92(11), 1557-1560.A.C.H. de Vries (Andrica), R.W. Stam (Ronald), P. Schneider (Pauline), C.M. Niemeyer (Charlotte), E.R. van Wering (Elisabeth), O.A. Haas (Oskar), C.P. Kratz (Christian), M.L. den Boer (Monique), R. Pieters (Rob) and M.M. van den Heuvel-Eibrink (Marry)
November 2007